Accession Number:

AD1094034

Title:

Patient Response to an Integrated Orthotic and Rehabilitation Initiative for Traumatic Injuries for the Military Treatment Facilities (PRIORITI-MTF)

Descriptive Note:

Technical Report,01 Jul 2012,30 Dec 2017

Corporate Author:

Johns Hopkins University Baltimore United States

Personal Author(s):

Report Date:

2018-03-01

Pagination or Media Count:

22.0

Abstract:

The Intrepid Dynamic Exoskeletal Orthosis IDEOtrademark is a custom, energy-storing carbon fiber ankle-foot orthosis developed for lower extremity trauma patients. Studies conducted at one military treatment facility MTF where the IDEOtrademark was developed demonstrated benefits of the IDEOtrademark when used with the Return to Run physical therapy program RTR PT. The PRIORITI-MTF study was designed to see if these results could be replicated at other MTFs and examine whether early performance gains translate into longer term improvements in patient-reported functional outcomes. Methods. Study participants included service members at least 1 year after a traumatic unilateral lower extremity injury at or below the knee with functional deficits interfering with daily activities. Participants were evaluated before receiving the IDEOtrademark, immediately following completion of PT, and at 6 and 12 months. Agility, strengthpower and speed were assessed using well-established performance tests. Self-reported function was measured using the Short Form Musculoskeletal Assessment SMFA. The Orthotics and Prosthetics Users Survey was administered to assess satisfaction with the IDEOtrademark. Of 87 participants with complete baseline data, 6 did not complete any PT and were excluded from analysis. Follow-up rates immediately following completion of the RTR PT and at 6 and 12 months were 88 percent, 75 percent and 79 percent. Results. Compared to baseline, improvement at completion of RTR PT was observed in all but 1 performance test. SMFA scores for all domains except ArmHand Function were lower improved function at 6 and 12 months. Satisfaction with the IDEOtrademark was high following completion of RTR PT with some attenuation at follow-up. Conclusion. This study adds to the evidence supporting the efficacy of the IDEOtrademark coupled with RTR PT.

Subject Categories:

  • Medicine and Medical Research
  • Weapons Effects (Biological)

Distribution Statement:

APPROVED FOR PUBLIC RELEASE